From digitally aging photos to nab murderers to recreating faces, AI is entering the beat as the trusted investigative ally of the police, writes Medha Shri ...

Let's make a real-time Facial Landmark Detection using OpenCV, Python, and Mediapipe API. It detects 468 facial landmarks in real time. Facial Landmark Detection is used for AR (Augmented Reality) ...

Save $50 on the Contour Face with our exclusive code during Omnilux's sale through tonight. After eight months of extensive testing nine popular LED face masks, our beauty editors say that the the ...

Abstract: The imbalance of ECG signal data and the complexity of labeling pose significant challenges for deep learning-based anomaly detection. Traditional contrastive learning approaches for ECG ...

Paul Hunter consults for the World Health Organization. He receives funding from National Institute for Health Research and has received funding from the World Health Organization and the European ...

Peter Greene, an actor noted for playing the character Zed in the classic film “Pulp Fiction,” was found dead inside his Lower East Side apartment on Friday, police and a neighbor told the Daily News.

Rubber duck debugging is a time-honored programming technique where developers explain their code, line-by-line, to an inanimate rubber duck. The simple act of verbalizing the problem often leads to ...

Abstract: Hyperspectral anomaly detection (HAD) aims to recognize a minority of anomalies that are spectrally different from their surrounding background without prior knowledge. Deep neural networks ...

When OpenAI CEO Sam Altman made the dramatic call for a “code red” last week to beat back a rising threat from Google, he put a notable priority at the top of his list of fixes. The world’s most ...

The study evaluated the efficacy and safety of the investigational immunotherapy combination of TECVAYLI ® plus DARZALEX FASPRO ® versus DARZALEX FASPRO ® and dexamethasone with either pomalidomide or ...

ORLANDO, Fla., Dec. 9, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that ...